These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 11120014)
41. Etiology of early renal allograft dysfunction after live donor renal transplantation. Morrissey PE; Gohh R; Madras PN; Shaffer D; Davis C; Conway P; Sahyoun A; Monaco AP Transplant Proc; 1998 Jun; 30(4):1320. PubMed ID: 9636536 [No Abstract] [Full Text] [Related]
42. Impact of the variability of cyclosporin A trough levels on long-term renal allograft function. Waiser J; Slowinski T; Brinker-Paschke A; Budde K; Schreiber M; Böhler T; Hauser I; Neumayer HH Nephrol Dial Transplant; 2002 Jul; 17(7):1310-7. PubMed ID: 12105257 [TBL] [Abstract][Full Text] [Related]
43. Eleven-year experience of kidney transplantation in patients with hepatitis B and C infection. Sumethkul V; Jirakranont B; Jirasiritham S; Pairoj W Transplant Proc; 2000 Nov; 32(7):1944-5. PubMed ID: 11120012 [No Abstract] [Full Text] [Related]
44. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients. Siu CW; Chan TM; Li FK; Choy BY; Lui SL; Lo CY; Tang S; Lo WK; Lai KN Transplant Proc; 2000 Nov; 32(7):1932-4. PubMed ID: 11120007 [No Abstract] [Full Text] [Related]
45. Comparison between three different antilymphocyte induction protocols in renal transplant recipients with delayed graft function. Sumrani N; Hong JH; DiBenedetto A; Clayton R; Miles AM; Markell MS; Distant DA; Fleishhacker J; Sommer BG Transplant Proc; 1996 Feb; 28(1):400-1. PubMed ID: 8644289 [No Abstract] [Full Text] [Related]
46. Liver function tests in hepatitis C virus infected kidney transplant recipients. Manfro RC; Karohl C; Goncalves LF; Senger MB; Thomé FS; Prompt CA Transplant Proc; 1995 Apr; 27(2):1821-2. PubMed ID: 7725519 [No Abstract] [Full Text] [Related]
47. Long-term results and risk factors of quadruple immunosuppression in renal transplantation. Hiesse C; Kriaa F; Eschwege P; Boubenider S; Marchand S; Benoit G; Charpentier B Transplant Proc; 1999; 31(1-2):1111-2. PubMed ID: 10083496 [No Abstract] [Full Text] [Related]
48. Harmful effects of viral replication in seropositive hepatitis C virus renal transplant recipients. Gentil Govantes MA; Esforzado N; Cruzado JM; González-Roncero FM; Balaña M; Saval N; Morales JM Transplantation; 2012 Dec; 94(11):1131-7. PubMed ID: 23104249 [TBL] [Abstract][Full Text] [Related]
49. Prevalence of antibodies to hepatitis C virus and correlation with liver disease in renal transplant patients. Rostaing L; Izopet J; Cisterne JM; Icart J; Chabannier MH; Panicali H; Durand D Am J Nephrol; 1997; 17(1):46-52. PubMed ID: 9057953 [TBL] [Abstract][Full Text] [Related]
50. Renal transplantation using hepatitis B or C serology-positive donors. Santos AF; Busetto F; Franco R; Keitel E; Bittar AE; Garcia VD Transplant Proc; 1997 Dec; 29(8):3320. PubMed ID: 9414733 [No Abstract] [Full Text] [Related]